The commensal fungus, Candida albicans, can cause life-threatening infections in at risk individuals. C. albicans colonizes mucosal surfaces of most people, adhering to and interacting with epithelial cells. At low concentrations, C. albicans is not pathogenic nor does it cause epithelial cell damage in vitro; at high concentrations, C. albicans causes mucosal infections and kills epithelial cells in vitro. Here we show that while there are quantitative dose-dependent differences in exposed epithelial cell populations, these reflect a fundamental qualitative difference in host cell response to C. albicans. Using transcriptional profiling experiments and real time PCR, we found that wild-type C. albicans induce dosedependent responses from a FaDu epithelial cell line. However, real time PCR and Western blot analysis using a high dose of various C. albicans strains demonstrated that these dosedependent responses are associated with ability to promote host cell damage. Our studies support the idea that epithelial cells play a key role in the immune system by monitoring the microbial community at mucosal surfaces and initiating defensive responses when this community is dysfunctional. This places epithelial cells at a pivotal position in the interaction with C. albicans as epithelial cells themselves promote C. albicans stimulated damage.
Introduction
Candida albicans is a natural isolate of the human oral-pharyngeal cavity and the gastro-intestinal and uro-genital tracks [1] . While C. albicans primarily colonizes these mucosal surfaces at low levels as a commensal, it can overgrow and cause superficial infections. For example, C. albicans is commonly present within the vaginal tract, yet most women suffer at least one episode of vulvovaginal candidiasis (VVC) and 5-10% of women suffer from recurrent VVC [2] . C. albicans can escape from mucosal sites in susceptible hosts and enter the bloodstream to cause life-threatening systemic candidiasis, which has an attributable mortality of 30-50% even with antifungal therapy [3] . Thus, the mucosal surface represents both the primary site of C. albicans-host interaction and the origin of serious clinical infections.
Mucosal surfaces are composed of one or more layers of epithelial cells and define the major interface between the environment and the host. For example, the intestinal epithelia of the ileum, jejunum, and colon have a single layer of columnar epithelial cells, whereas other mucosal tissues have layers of stratified epithelial cells. Mucosal tissues also contain resident immune cells, including dendritic cells, macrophage, and T-cells. These cells are often found in immunologic foci such as Peyer's patches, nasopharynx associated lymphoid tissue, or oral lymphoid foci and/or are distributed throughout the sub-mucosa adjacent to the epithelial surface. Epithelial cells play a key role in signaling immune cells and the epithelial surface is an active and essential component of innate immunity. Thus, epithelial cells represent the first line of defense against C. albicans infections.
To gain a clear understanding of C. albicans pathogenesis, it is essential to understand the initial interactions between C. albicans and mucosal epithelial cells. Most studies addressing C. albicans host-pathogen interactions have focused on C. albicans in systemic infection models and have identified a plethora of C. albicans genetic requirements for pathogenesis. These studies focus on events occurring after C. albicans has escaped from the mucosal surface frequently overlook the role of the host in C. albicans host-pathogen interactions.
Several models have been developed to study the interaction between C. albicans and epithelial cells, which have led to a number of important insights. Filler and colleagues established an in vitro model of C. albicans mediated epithelial cell damage [4] . In this model, C. albicans yeast cells germinate to form hyphae and adhere to the epithelial cell monolayer. Epithelial cells then phagocytose portions of the hyphae, leading to C. albicans-mediated epithelial cell lysis. This model has revealed molecular details likely involved in dissemination and is key for continued understanding of C. albicans pathogenesis. For example, the C. albicans adhesin Als3 binds to epithelial cell E-cadherin and this interaction is important for epithelial cell damage [5] . Using a reconstituted epithelial cell model, Villar and colleagues found that the C. albicans secreted aspartyl protease (Sap) Sap5 degrades epithelial cell E-cadherin promoting tissue invasion [6] . ALS3 and SAP5 are induced by the pH responsive transcription factor Rim101 [6, 7] , suggesting that Rim101 governs two interactions with the mucosal surface. In addition to providing key insights into C. albicans pathogenesis, these studies have also demonstrated that host responses are critical components of fungal-induced tissue damage. For example, inhibition of host cell phagocytosis of C. albicans hyphae completely blocks host cell damage [8] .
While recognition and understanding the host side of the C. albicans-epithelial cell interaction is still in its infancy, studies with other pathogenic microbes have demonstrated the key roles epithelial cells play in innate immunity. Epithelial cells sense environmental microbes using a set of pattern recognition receptors (PRRs), such as the Toll-like receptors (TLRs), which recognize common microbial motifs. TLR2 and TLR4 have been implicated in sensing C. albicans [9, 10] . Activated PRRs stimulate downstream MAP kinases, such as ERK1/22, JNK1/2, and p38, which phosphorylate and activate transcription factors, including AP-1 or CREB, inducing immune and inflammatory responses, like expression of IL-8. These inflammatory responses activate resident immune effector cells, such as macrophages, and recruit additional effector cells, including neutrophils, to sites of infection. Thus, epithelial cells are poised at the front line to sense and respond to C. albicans cells at the mucosal surface.
Many of the previous studies of C. albicans-epithelial cell interactions arise from the premise that C. albicans is a pathogen. In the vast majority of the human population however, C. albicans is simply a commensal. This leads to the fundamental question, what distinguishes C. albicans in the commensal state compared with the pathogenic state? One possibility is that C. albicans is inherently pathogenic. In this model, at low fungal cell density, manifestation of disease is sub-clinical and C. albicans is considered a benign agent; at high cell density disease, is readily apparent and C. albicans is considered a pathogen. However, when low concentrations of C. albicans are added to primary epithelial cells, C. albicans proliferate and form microcolonies on the surface of the epithelial cells without overt epithelial cell disruption [11] , suggesting that 'inherent pathogenicity' is not sufficient to explain the observed difference between the commensal and pathogenic states. Another possibility is that the host itself, specifically epithelial cell responses contribute to the transition to the pathogenic state. For example, at low fungal cell density, epithelial cells may not respond to C. albicans. However, at high cell density, epithelial cells may respond in a way that elicits the expression of pathogenic traits in C. albicans. Indeed, a major area of current study is how the innate immune system distinguishes beneficial or commensal microbes from pathogens.
Here, we used the human FaDu epithelial cell line model to study epithelial cell responses to C. albicans. We found that some epithelial cell transcriptional responses are dependent on the dose of C. albicans used to initiate infection, whereas other responses are dose-independent. We found that members of the dual specificity phosphatase (DUSP) family are induced in response to C. albicans and that this induction is clearly linked to the activation of MAP kinases. These studies further define the epithelial cell response to C. albicans and to address the host response to a normal component of human flora.
Materials and Methods

Media and Growth Conditions
FaDu cells (ATCC, cat #30-2003) were routinely grown in MEM medium containing 10% FBS and 500 U/ml penicillin, 500 μg/ml streptomycin (Pen/Strep), and 1.25 μg/ml amphotericin B at 37°C in 5% CO 2 . For infection studies with fungi, amphotericin B was omitted from the tissue culture medium.
C. albicans strains (DAY185-wild-type, DAY25-rim101Δ/Δ, and DAY1175-efg1Δ/Δ cph1Δ/Δ) and S. cerevisiae (DAY414) were routinely grown in YPD (2% Bacto-peptone, 1% yeast extract, 2% dextrose) at 30°C [12] [13] [14] . For infections studies, C. albicans were grown in YPD overnight at 30°C. Cells were diluted 1:100 in DMEM, sonicated, and counted on a hemacytometer. C. albicans were diluted as appropriate in pre-warmed in DMEM containing 10% FBS and 200 units/ml of penicillin and streptomycin prior to adding to host cells.
RNA Purification
Total RNA was isolated using TRIzol R reagent (Invitrogen) and treated with DNAse I (Roche) for 30 minutes at 25°C. RNA was purified using an RNeasy mini column (Qiagen, Valencia CA) and eluted with nuclease free ddH 2 O. RNA concentration was determined using the NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, Inc., Wilmington, DE).
Microarrays
FaDu cell gene expression profiles were determined in triplicate with and without C. albicans using GeneChip R HG-U133A 2.0 Microarrays (Affymetrix, Santa Clara CA). FaDu cells were split into 100 mm cell culture petri dishes and grown to~95% confluency. Fresh DMEM containing 10%FBS and Pen/Strep with or without C. albicans was added and incubated as described in the text. 5-8 μg of purified RNA was processed using Affmetrix automated GeneChip R standard protocols by the Microarray Facility at the Biomedical Genomics Center (U of MN). Gene expression values were determined using the Affymetrix Microarray Analysis Suite (MAS) 5.0 and chip-to-chip normalization with LOWESS done using Genedata Expressionist Pro 4.5. The Paired T-test was used to compare the control and test groups and genes differentially expressed 1.5 with a P value < 0.05 were examined. 
Real Time RT-PCR
Protein Purification and Analysis
FaDu cells monolayers were placed on ice and washed 2x with ice cold PBS containing protease inhibitor cocktail (1ng/ml leupeptin, 2ng/ml pepstatin, 100ng/ml aprotinin, and 1mM PMSF). 0.7ml of lysis buffer (40 mM Tris pH 6.8, 1% SDS, 10% Glycerol, 2% β-mercaptoethanol, 0.01% Bromophenol Blue) was added and cells removed from the tissue culture plate using a cell scraper. Cells were transferred to a 2 ml screw capped tube, boil 5 minutes and stored at -80°C. For Western blots, protein samples were thawed and boiled for 5 minutes and separated by 10% SDS-PAGE. Gels were transferred to nitrocellulose (Millipore Corp., Billerica, MA) and stained with 0.1% Ponceau S in 5% acetic acid to qualitatively assess loading and transfer. The blots were washed with ddH 2 O and blocked in TBS-T (50 mM Tris pH 7.6, 150 mM NaCl, 0.05% Tween-20) containing either 5% non-fat dairy milk or 5% BSA at 4°C. 1:1000-1:10,000 dilution of primary antibody, in blocking solution, was added according to manufacturer specifications and incubated overnight at 4°C or for 1 hour at 23°C. Primary antibodies used in this study are ⍺-Phospho-p42/44 MAPK (ERK1/2) and ⍺-phospho-JNK1/2 (Invitrogen) and ⍺-GAPDH (Cell Signaling Tech). The blots were washed 3 times with TBS-T at 23°C for 5 minutes and then 1:5000 HRP-donkey anti-rabbit IgG (Amersham Biosciences) was added for 1 hr at 23°C in 5% non-fat dairy milk in TBS-T. Blots were washed 3 times with TBS-T at 23°C for 5 minutes. Blots were treated with ECL Western Blotting Detection Reagents (Amersham Biosciences) and exposed to film. Films were analyzed using ImageJ version 1.38 (NIH) and bands normalized to GAPDH.T able 1. Primer sets used for RT-PCR.
Gene name
Assay ID
HPRT Hs99999909_m1
DUSP 1 Hs00610256_g1
DUSP 6 Hs00169257_m1
Interleukin 1 alpha Hs00174092_m1
Interleukin 6 Hs00174131_m1
Interleukin 8 Hs00174103_m1
Interleukin 24 Hs01114274_m1
SERPIN E1 Hs00167155_m1
doi:10.1371/journal.pone.0153165.t001
Results
FaDu Cell Responses to C. albicans
C. albicans is part of the normal gastro-intestinal flora. To understand the host-pathogen interaction, it is essential to identify relevant host markers of pathogenesis. Thus, we used a human epithelial cell tissue culture model to identify transcriptional changes associated with C. albicans infection. Transcriptional profiling experiments were conducted using the FaDu cell line, an immortalized epithelial-like cell line derived from the oral-pharyngeal cavity of a male patient [15] . We chose this cell line as it is routinely used to study C. albicans-mediated host cell damage [4, 16] . Infection with high concentrations of C. albicans leads to rapid killing of epithelial cells [7, 17 ], yet we found that infection with low concentrations of C. albicans leads to proliferation on the surface of the epithelial cells without causing overt damage [11] . These results suggest that epithelial cell-C. albicans interactions vary depending on fungal concentration. We tested this idea by analyzing epithelial cell transcriptional responses following infection with a low or a high dose of C. albicans. A 95% confluent monolayer of FaDu cells was infected for 6 hours with either 2.0 x 10 4 cells/ml (low dose) or 2.5 x 10 6 cells/ml (high dose) of wild-type C. albicans and epithelial cell transcriptional responses determined using Affymetrix gene chips. We chose the 6 hours time point to maximize the interaction time between host and microbe to allow host transcriptional responses to occur before C. albicans-mediated lethality is observed [17] . FaDu cells infected with a low dose of wild-type C. albicans differentially expressed 90 genes. Of these, 44 genes were down-regulated 1.5-fold and 46 genes were up-regulated 1.5-fold compared to uninfected controls (S1 Table) . However, FaDu cells infected with a high dose of C. albicans differentially expressed 702 genes, of which, 309 were down-regulated 1.5-fold and 393 were up-regulated 1.5-fold compared to uninfected controls S2 Table. The high dose of C. albicans elicited a greater transcriptional response from the epithelial cells than the low dose of C. albicans. However, we were surprised to find that only~25% (21/ 90) of the genes differentially expressed in response to the low dose of C. albicans were also differentially expressed in response to a high dose of C. albicans (Table 2) . Of these 21 genes, 14 genes were induced > 2 fold and one gene, F5, was repressed > 2 fold in response to the high dose of C. albicans compared to a low dose of C. albicans (Table 2) . One possibile explanation for these results is that they are due to weak induction under one condition that is not apparent in the other condition. However, three genes (SLC26A3, MFAP5, and TACR1) are induced > 5 fold in response to a low dose, but are not observed among the genes induced in response to a high dose of C. albicans. In fact using a > 3 fold change in gene expression revealed that of nine genes differentially expressed in epithelial cells in response to a low dose of C. albicans, only four genes were also differentially expressed in response to a high dose of C. albicans (Fig 1) . These results demonstrate that while 21 host genes show potential dose-dependent expression, many of the observed transcriptional responses are not readily explained by a dose-dependent model.
To gain insights into the likely host cell responses to C. albicans, we analyzed the transcriptional profiling data via gene ontogeny (GO) analysis [18, 19] (Tables 3 and 4 ). Epithelial cells exposed to either a low or a high dose of C. albicans induced genes associated with apoptosis, the inflammatory response, and the response to stress (P value < 0.01). However, epithelial cells exposed to a high dose of C. albicans also induced genes associated with chemotaxis and host-pathogen linked responses (P value < 0.001) (Table 3) . Additionally, epithelial cells exposed to a high dose of C. albicans, repressed genes associated with the cell cycle and macromolecular synthesis (Table 4) . No GO categories were repressed with statistical significance in response to the low dose of C. albicans.
Innate inflammatory responses are essential in controlling C. albicans infections, thus we more closely analyzed the genes in the 'inflammatory response' GO category ( Table 5 ). The low dose of C. albicans caused the specific induction of SERPIN A3, and TACR1; both low and high doses induced FOS, IL-8, and PTGS2 (COX-2). FOS, a component of the AP-1 transcription factor, regulates IL-8 and PTGS2 expression [20, 21] . The high dose of C. albicans induced fifteen additional genes, including the chemokines CCL20, CXCL1, CXCL2, CXCL3, and CXCL12 as well as IL-1⍺, IL-1β, and IL-6. IL-8, CCL20, CXCL1, and CXCL3 function in neutrophil recruitment and it is widely recognized that neutrophils are potent anti-Candida leukocytes. CXCR4, the CXCL12 receptor, is also induced suggesting the possibility an autocrine feedback pathway. Several of these host cell responses to C. albicans, such as IL-8 induction, have been reported previously, providing independent validation for the new responses identified here. We noted that 6 members of the DUSP gene family were induced in response to C. albicans infection. DUSP1 was induced by both the low and high doses of C. albicans; DUSP4, 5, 6, 7, and 10 were induced in response to a high dose of C. albicans. The DUSP gene family encodes protein phosphatases that inactivate MAP kinases. DUSP proteins regulate inflammatory responses and mice lacking DUSP1 have increased cytokine expression and increased sepsis in response to endotoxin [22, 23] .
Host Responses Are Dependent on the Ability of C. albicans to Cause Damage
Our transcriptional profiling studies suggest that the transcriptional responses of FaDu cells to C. albicans are not all dose-dependent (S1 and S2 Tables and Tables 3 and 4) . Thus, we posited a different model where a subset of host responses is dependent on the ability of C. albicans to induce damage. We predicted that when C. albicans is not promoting damage, the host response resembles that observed in our low dose studies. To address this idea, we analyzed host responses after exposure to a high dose of mutant C. albicans cells that have reduced abilities to cause host cell damage. Specifically, we used the rim101Δ/Δ mutant, which elicits~5% killing, and the efg1Δ/Δ cph1Δ/Δ mutant, which does not promote epithelial cell lysis [4, 7] . We also analyzed S. cerevisiae as a control, which does not adhere to nor promote epithelial cell damage [24] . We considered that differences in epithelial transcriptional responses to the C. albicans mutants could be due to kinetic differences associated with the interaction between the mutants and epithelial cells and not a fundamental difference in the interaction itself. To control for this, we used real time RT-PCR to compare gene expression changes over 32 hours (compared with the 6 hour snap shot used in the original microarrays). We were also concerned that the differences in the yeast-hyphal morphological transition, which is critical for pathogenesis, would promote distinct host cell responses [25] . We found that wild-type yeast cells germinated hyphae within 1 hour post-infection (Fig 2) . The hyphae continued to grow over the epithelial cells and formed a hyphal mat within 8 hours. The rim101Δ/Δ mutant also germinated to form hyphae within 1 hour post-infection. However, unlike wild-type C. albicans, the rim101Δ/Δ mutant hyphae grew more slowly and only began branching by 4 hours post-infection. Eight hours post-infection, the rim101Δ/Δ mutant had not formed a complete mat, likely due to the shorter branching hyphae. The efg1Δ/Δ cph1Δ/Δ mutant grew in the yeast form throughout the 32 hour incubation and unlike the wild-type and rim101Δ/Δ cells, the Epithelial Cell Responses to C. albicans efg1Δ/Δ cph1Δ/Δ mutant was non-adherent and could be dislodged from the epithelial cells with gentle agitation. Thus, if a host response is due to C. albicans morphology, the rim101Δ/Δ mutant should show a kinetic defect due to the less robust hyphal formation and the same effect should be absent in the efg1Δ/Δ cph1Δ/Δ mutant and S. cerevisiae, which do not form hyphae. IL-8 and SERPIN E1 were induced 3 hours post-infection with wild-type C. albicans and reached a maximal level of induction 8 hours post-infection (Fig 3) . Similar results were observed when epithelial cells were infected with the rim101Δ/Δ mutant. However, when epithelial cells were exposed to a high dose of the efg1Δ/Δ cph1Δ/Δ mutant, IL-8 and SERPIN E1 expression were induced~14 hours post-infection and only reached~50% of the level observed with exposure to either the wild-type or rim101Δ/Δ strains. S. cerevisiae did not induce IL-8 or SERPIN E1 expression, even after 32 hours of co-culture.
IL-6 and IL-1⍺ were induced 5 hours post-infection with wild-type C. albicans cells. However, when epithelial cells were infected with a high dose of the rim101Δ/Δ mutant, IL-6 and IL-1⍺ were expressed~8-9 hours post-infection. Infection of the epithelial cells with the efg1Δ/ Δ cph1Δ/Δ mutant induced IL-6 and IL-1⍺~9 and 14 hours post-infection respectively. S. cerevisiae did not induce IL-6 and IL-1⍺ expression during the 32 hour incubation.
DUSP1, IL-24, and DUSP6 were induced 2-3 hours post-infection with the high dose of wild-type C. albicans and reached a maximal level of induction~6 hours post-infection. DUSP1 was induced in epithelial cells~6 hours post-infection and reached a maximal level after 8 hours following infection with the rim101Δ/Δ mutant. However, the rim101Δ/Δ mutant did not induce IL-24 or DUSP6 expression. Neither the efg1Δ/Δcph1Δ/Δ mutant nor S. cerevisiae induced DUSP1, IL-24, or DUSP6 expression over the 32 hours of co-culture.
In total, wild-type C. albicans cells rapidly induced host cell expression of all tested genes and reached a maximum within 5 hours post-infection. The rim101Δ/Δ mutant showed similar induction (IL-8), delayed induction (DUSP1), or no induction (DUSP6) of host responses; the efg1Δ/Δcph1Δ/Δ mutant showed delayed (IL-8) or no induction (DUSP1) of host responses. These results collectively support the idea that a subset of the induced host cell responses are not fungal dose-dependent, but may instead be dependent on host cell damage. Epithelial Cells Activate MAP Kinases upon Exposure to C. albicans
In response to pathogenic microbes, epithelial cells stimulate mitogen activated protein (MAP) kinases, which promote transcription factor activity. Our transcriptional profiling experiments suggest that MAP kinases are activated via phosphorylation in response to C. albicans. To directly test this possibility, we analyzed MAP kinase phosphorylation following exposure to wild-type and mutant C. albicans and S. cerevisiae.
The JNK1/2 MAP kinases were phosphorylated 3 hours post-infection with wild-type C. albicans (Fig 4A) . JNK1/2 phosphorylation was maintained until 7 hours post-infection when phosphorylation was reduced to background levels. JNK1/2 phosphorylation was delayed and only observed 4-6 hours following infection with the rim101Δ/Δ mutant. JNK1/2 phosphorylation was also markedly reduced during infection with the rim101Δ/Δ mutant when compared to infection by wild-type C. albicans. No JNK1/2 phosphorylation was observed when epithelial cells were infected with the efg1Δ/Δ cph1Δ/Δ mutant nor with S. cerevisiae. These results demonstrate that robust JNK1/2 phosphorylation occurs in response to wild-type C. albicans and is reduced or absent in response to less pathogenic strains.
The ERK1/2 MAP kinases were phosphorylated 2 hours post-infection with wild-type C. albicans and the phosphorylated state was maintained until 7 hours post-infection (Fig 4B) . Little ERK1/2 phosphorylation was observed following infection with the rim101Δ/Δ mutant and no ERK1/2 phosphorylation was observed following infection with the efg1Δ/Δ cph1Δ/Δ mutant nor with S. cerevisiae. Similar results were observed for p38 phosphorylation (data not shown). These results confirm that wild-type C. albicans promote robust MAP kinase activation.
Discussion
The ability of the immune system to distinguish between commensal and pathogenic microbes is critical to host survival. As the primary cell type at the interface between the external environment and internal host tissues, epithelial cells are key players in this role. Inappropriate responses to commensal organisms at the mucosa by epithelial cells can lead to chronic inflammation with clinical manifestations [26, 27] . Conversely, if commensals are completely ignored, then those with disease causing potential, such as C. albicans, can overgrow and cause disease. The current paradigm is that the host is aware of, but not responsive to, commensal microbes.
Here, we found that the FaDu epithelial-like cell line does respond to a dose of C. albicans that causes little if any damage (Tables 2-5) . When compared to a dose of C. albicans that causes extensive damage, these low-dose responses were both quantitatively diminished and qualitatively distinct. While some of these responses did appear to be dose-dependent, others were not and appeared associated with the yeast-hyphal transition and/or ability of C. albicans to cause damage. Induction of epithelial responses was correlated with phosphorylation of epithelial MAP kinases and involved induction of the DUSP protein family.
The low or 'commensal' dose of C. albicans used in these studies led to the induction of a small number of genes involved in stress and inflammatory responses, such as IL-8. However, most genes involved in inflammatory responses were not induced, suggesting that the epithelial cells have recognized the C. albicans cells and entered into a sentinel mode: awareness without overt changes in homeostatic processes. The high or 'pathogenic' dose of C. albicans led to the induction of many genes involved in stress and inflammatory responses, as well as genes involved in other immune responses and chemotaxis (Table 3) . These results indicate that the epithelial cells have entered into a defensive mode: potentiating immunological responses, recruiting effector cells, and halting other activities including growth. Where host responses to a low or high dose of C. albicans overlap, such as with FOS, JUN, and IL-8 expression, the high dose of C. albicans generally elicited a greater effect on gene expression than the low dose. This idea of epithelial cells having sentinel and defensive roles has been suggested previously [26, 27] , including for C. albicans [28] . One explanation for the change from a sentinel state to a more active defensive state is the number of C. albicans cells interacting with the epithelial surface. Indeed, of the host cell genes differentially expressed in response to C. albicans,~90% (including those only induced in response to the high dose of C. albicans) could be explained using a dose-dependent model. The proximate causes underlying dose-dependent differences in host-C. albicans interactions are currently unknown and could be mediated by either the host or the pathogen. While most host responses are explained using a dose-dependent model, we have identified numerous host responses that are not. Furthermore, our analyses using a high dose of wild-type and mutant C. albicans suggest that many dose-dependent changes must be affected by more than just the absolute numbers of C. albicans cells. Two hours post-infection cell numbers among the wild-type, rim101Δ/Δ, and efg1Δ/Δ cph1Δ/Δ strains are similar (Fig 2) , yet epithelial cells induced DUSP6 only in response to wild-type C. albicans (Fig 3) . Neither mutant significantly induced DUSP6 over the 32 hour time course despite the fact that both mutants grew and reached concentrations much greater than that observed when DUSP6 was induced by wild-type C. albicans. Furthermore, in some cases the rim101Δ/Δ mutant elicited host responses that matched wild-type C. albicans, such as SERPIN E1, and in other cases the rim101Δ/Δ mutant elicited host responses that matched the efg1Δ/Δ cph1Δ/ Δ mutant, such as IL-6. Thus, differences in C. albicans dose are not sufficient to explain many observed host responses.
Because C. albicans morphology can influence host responses [29] , we also considered whether the morphogenetic differences observed in the various C. albicans mutants provide insight into host cell responses. However, morphogenetic differences did not appear sufficient to predict host cell responses. For example, if this model were correct, epithelial transcriptional responses to the high and low dose of wild-type C. albicans should be similar as C. albicans grow in the hyphal form on the surface of epithelial cells regardless of dose. Furthermore, as noted above the rim101Δ/Δ mutant formed hyphae with delayed kinetics compared to wild-type cells yet frequently did not show an associated host response, such as DUSP6 induction.
One C. albicans property that is associated with both dose and morphogenetic potential and predicts host cell responses is the ability to promote epithelial cell damage. In previous studies with the FaDu epithelial cell line, wild-type C. albicans elicited~25% host cell killing, while the rim101Δ/Δ mutant elicited~5% killing, and efg1Δ/Δ cph1Δ/Δ cells did not promote epithelial cell damage [4, 7] . While S. cerevisiae has not been studied in this specific model, it does not adhere to host cells, nor does it promote damage in other models [24] . Thus, with respect to the ability to kill epithelial cells in culture: wild-type > rim101Δ/Δ > efg1Δ/Δ cph1Δ/Δ = S. cerevisiae. This same relationship between fungal strain and epithelial damage in host cell responses was also observed for JNK1/2 phosphorylation: wild-type C. albicans promote more JNK1/2 phosphorylation than the rim101Δ/Δ mutant, which promotes more JNK1/2 phosphorylation than the efg1Δ/Δ cph1Δ/Δ mutant or S. cerevisiae. Since JNK1/2 phosphorylation occurs well before host cell death mediated by wild-type C. albicans, JNK1/2 phosphorylation predicts the gene expression changes observed in the FaDu epithelial cells in response to a high and low dose of C. albicans as well as to the high dose of C. albicans mutant strains. Based on these transcriptional studies, we propose a differential-interaction model where some interactions between epithelial cells and a high dose of C. albicans are qualitatively distinct from the interaction between epithelial cells and a low dose of C. albicans. Host cell killing is a qualitative distinction that distinguishes the high and low doses of C. albicans as well as the separate mutant strains studied here.
Are These Studies Applicable to Human Invasive Infections?
One potential limitation of the transcriptional studies is that a single epithelial cell line was used raising the question of general applicability. However, the overlap between our analyses and other microbial-epithelial cell interaction studies suggests that our results are providing relevant data. First, our transcriptional results overlap well with those obtained by Barker et al. who identified endothelial cell responses to C. albicans and Liu et al. who used RNA-seq to identify epithelial and endothelial cell responses in C. albicans [30, 31] . Indeed, we observed NEDD9 up-regulation in response to a high dose of C. albicans, but not a low dose of C. albicans S2 Table, which Liu et al found to be important for host cell endocytosis of C. albicans hyphae [31] . We also find much overlap between our results and those of Howie et al. studying T84 human colonic epidermoid cell responses to Neisseria gonorrhoeae, including the induction of DUSP1, DUSP2, and DUSP5 [32] . Second, many of the transcriptional responses we observed are predicted if the MAP kinase cascades are activated, which we found to be the case. While we are confident that the FaDu cell line revealed host responses relevant to the in vivo scenario, the cell line does have limitations. For example, only restricted aspects of pathogenesis can be analyzed using this, or any other, cell line, including pathogen adherence and host cell damage. Furthermore, we have found that FaDu epithelial cells lack certain properties found in "normal" epithelial cells. When exposed to FaDu epithelial cells, rim101Δ/Δ mutants can germinate and grow as hyphae (Fig 2) . However, rim101Δ/Δ mutants grow only in the yeast form in animal models [33] . Since the mammalian model is analogous to the human, as compared to an immortalized and transformed cell line, we infer that the inhibition of rim101Δ/Δ hyphal growth in the animal model is an attribute of epithelial cells that has been lost in the FaDu cell line.
Supporting Information S1 Table. Genes differentially expressed 1.5 fold in epithelial cells in response to a low dose of C. albicans. (XLSX) S2 Table. Genes differentially expressed 1.5 fold in epithelial cells in response to a high dose of C. albicans. (XLSX)
